Breast Cancer: Recurrent Genomic Alterations: Difference between revisions
| [unchecked revision] | [unchecked revision] |
mNo edit summary |
No edit summary |
||
| Line 93: | Line 93: | ||
|PARP inhibitors (germline) | |PARP inhibitors (germline) | ||
|- | |- | ||
|''[[ | |''[[BRCA1]], [[BRCA2]]'' | ||
|1 | |1 | ||
|Often hereditary risk; TNBC | |Often hereditary risk; TNBC | ||